69 related articles for article (PubMed ID: 30522111)
1. miR-122 Targets X-Linked Inhibitor of Apoptosis Protein to Sensitize Oxaliplatin-Resistant Colorectal Cancer Cells to Oxaliplatin-Mediated Cytotoxicity.
Hua Y; Zhu Y; Zhang J; Zhu Z; Ning Z; Chen H; Liu L; Chen Z; Meng Z
Cell Physiol Biochem; 2018; 51(5):2148-2159. PubMed ID: 30522111
[TBL] [Abstract][Full Text] [Related]
2. ASR352, A potent anticancer agent: Synthesis, preliminary SAR, and biological activities against colorectal cancer bulk, 5-fluorouracil/oxaliplatin resistant and stem cells.
Narayan S; Ramisetti S; Jaiswal AS; Law BK; Singh-Pillay A; Singh P; Amin S; Sharma AK
Eur J Med Chem; 2019 Jan; 161():456-467. PubMed ID: 30384048
[TBL] [Abstract][Full Text] [Related]
3. SNHG4-mediated PTEN destabilization confers oxaliplatin resistance in colorectal cancer cells by inhibiting ferroptosis.
Li SQ; Xu WT; Yin YX; Wei HT; Li KZ; Xie MZ; Lv F; Xie LY; Hu BL
Apoptosis; 2024 Jun; 29(5-6):835-848. PubMed ID: 38573492
[TBL] [Abstract][Full Text] [Related]
4. Hsa_circ_0079662 induces the resistance mechanism of the chemotherapy drug oxaliplatin through the TNF-α pathway in human colon cancer.
Lai M; Liu G; Li R; Bai H; Zhao J; Xiao P; Mei J
J Cell Mol Med; 2020 May; 24(9):5021-5027. PubMed ID: 32243061
[TBL] [Abstract][Full Text] [Related]
5. APOA5 alleviates reactive oxygen species to promote oxaliplatin resistance in PIK3CA-mutated colorectal cancer.
Liu YL; Xiang Z; Zhang BY; Zou YW; Chen GL; Yin L; Shi YL; Xu LL; Bi J; Wang Q
Aging (Albany NY); 2024 Jun; 16(11):9410-9436. PubMed ID: 38848145
[TBL] [Abstract][Full Text] [Related]
6. Ketogenesis attenuated KLF5 disrupts iron homeostasis via LIF to confer oxaliplatin vulnerability in colorectal cancer.
Jiang H; Zeng Y; Jiang X; Xu X; Zhao L; Yuan X; Xu J; Zhao M; Wu F; Li G
Biochim Biophys Acta Mol Basis Dis; 2024 Aug; 1870(6):167210. PubMed ID: 38704001
[TBL] [Abstract][Full Text] [Related]
7. lncRNA-encoded pep-AP attenuates the pentose phosphate pathway and sensitizes colorectal cancer cells to Oxaliplatin.
Wang X; Zhang H; Yin S; Yang Y; Yang H; Yang J; Zhou Z; Li S; Ying G; Ba Y
EMBO Rep; 2022 Jan; 23(1):e53140. PubMed ID: 34779552
[TBL] [Abstract][Full Text] [Related]
8. TMPRSS13 promotes cell survival, invasion, and resistance to drug-induced apoptosis in colorectal cancer.
Varela FA; Foust VL; Hyland TE; Sala-Hamrick KE; Mackinder JR; Martin CE; Murray AS; Todi SV; List K
Sci Rep; 2020 Aug; 10(1):13896. PubMed ID: 32807808
[TBL] [Abstract][Full Text] [Related]
9. Gfi-1 modulates HMGB1-Mediated autophagy to overcome oxaliplatin resistance in colorectal cancer.
Liu W; Zhang Z; Zhang L; Jiang X; Chen C; Wu X; Zhao Q
Heliyon; 2024 May; 10(9):e29859. PubMed ID: 38694127
[TBL] [Abstract][Full Text] [Related]
10. RNA-seq identifies determinants of oxaliplatin sensitivity in colorectal cancer cell lines.
Li XX; Peng JJ; Liang L; Huang LY; Li DW; Shi DB; Zheng HT; Cai SJ
Int J Clin Exp Pathol; 2014; 7(7):3763-70. PubMed ID: 25120752
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of hCINAP sensitizes colorectal cancer cells to ionizing radiation.
Shen M; Zhang Y; Wu F; Shen M; Zhang S; Guo Y; Gan J; Wang R
Cell Cycle; 2024 Feb; 23(3):233-247. PubMed ID: 38551450
[TBL] [Abstract][Full Text] [Related]
12. Combinatory Treatment with miR-7-5p and Drug-Loaded Cubosomes Effectively Impairs Cancer Cells.
Gajda E; Godlewska M; Mariak Z; Nazaruk E; Gawel D
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708846
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-298 determines the radio-resistance of colorectal cancer cells by directly targeting human dual-specificity tyrosine(Y)-regulated kinase 1A.
Shen MZ; Zhang Y; Wu F; Shen MZ; Liang JL; Zhang XL; Liu XJ; Li XS; Wang RS
World J Gastrointest Oncol; 2024 Apr; 16(4):1453-1464. PubMed ID: 38660649
[TBL] [Abstract][Full Text] [Related]
14. Combinatorial Implications of Nrf2 Inhibitors with FN3K Inhibitor:
Beeraka NM; Zhang J; Zhao D; Liu J; A U C; Vikram Pr H; Shivaprakash P; Bannimath N; Manogaran P; Sinelnikov MY; Bannimath G; Fan R
Curr Pharm Des; 2023; 29(30):2408-2425. PubMed ID: 37861038
[TBL] [Abstract][Full Text] [Related]
15. Induction of resistance to oxaliplatin in cancer by a microRNA/Fem1B/Gli1 pathway.
Su YC; Metzen LT; Vélez LM; Bournique E; Seldin M; Buisson R; Kuo WW; Huang CY; Kaiser P
Am J Cancer Res; 2023; 13(12):6011-6025. PubMed ID: 38187042
[TBL] [Abstract][Full Text] [Related]
16. In vitro discovery of promising anti-cancer drug combinations using iterative maximisation of a therapeutic index.
Kashif M; Andersson C; Hassan S; Karlsson H; Senkowski W; Fryknäs M; Nygren P; Larsson R; Gustafsson MG
Sci Rep; 2015 Sep; 5():14118. PubMed ID: 26392291
[TBL] [Abstract][Full Text] [Related]
17. Novel chromium (III)-based compound for inhibition of oxaliplatin-resistant colorectal cancer progression.
Chen MC; Devi HS; Pien HF; Wen SF; Sheu JL; Tsai BC; Huang CY; Lin YJ
Am J Cancer Res; 2024; 14(3):979-995. PubMed ID: 38590406
[TBL] [Abstract][Full Text] [Related]
18. Fisetin and/or capecitabine causes changes in apoptosis pathways in capecitabine-resistant colorectal cancer cell lines.
Zehra K; Banu A; Can E; Hülya C
Naunyn Schmiedebergs Arch Pharmacol; 2024 May; ():. PubMed ID: 38748229
[TBL] [Abstract][Full Text] [Related]
19. Gastric Adenocarcinoma Predictive Long Intergenic Non-Coding RNA Promotes Tumor Occurrence and Progression in Non-Small Cell Lung Cancer via Regulation of the miR-661/eEF2K Signaling Pathway.
Gu H; Chen J; Song Y; Shao H
Cell Physiol Biochem; 2018; 51(5):2136-2147. PubMed ID: 30522114
[TBL] [Abstract][Full Text] [Related]
20.
Martín-Garcia D; Navarro A; Valdés-Mas R; Clot G; Gutiérrez-Abril J; Prieto M; Ribera-Cortada I; Woroniecka R; Rymkiewicz G; Bens S; de Leval L; Rosenwald A; Ferry JA; Hsi ED; Fu K; Delabie J; Weisenburger D; de Jong D; Climent F; O'Connor SJ; Swerdlow SH; Torrents D; Beltran S; Espinet B; González-Farré B; Veloza L; Costa D; Matutes E; Siebert R; Ott G; Quintanilla-Martinez L; Jaffe ES; López-Otín C; Salaverria I; Puente XS; Campo E; Beà S
Blood; 2019 Feb; 133(9):940-951. PubMed ID: 30538135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
